Status:
COMPLETED
Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Measles
Mumps
Eligibility:
All Genders
12-15 years
Phase:
PHASE3
Brief Summary
This study will assess the safety and immunogenicity of ProQuad when administered concomitantly and nonconcomitantly with Tripedia and Comvax.
Eligibility Criteria
Inclusion
- In good health
- Negative clinical history of varicella, zoster, measles, mumps, rubella, diptheria, tetanus, pertussis, invasive Hib disease and hepatitis B
- Had completed either a 2-dose primary series of PedvaxHIB or COMVAX or any 3-dose primary series of a licensed Hib vaccine
- Had received 2 or 3 doses of any hepatitis B vaccine or COMVAX prior to entry into trial
Exclusion
- Previous receipt of measles, mumps, rubella or varicella vaccine either alone or in combination
- Any immune impairment or deficiency
- Recent household, daycare or school exposure to invasive Hib disease or hepatitis B
- Exposure to measles, mumps, rubella, varicella, or zoster in the 4 weeks prior to vaccination
- Vaccination with an inactive vaccine with in the past 14 days
- Vaccination with a live vaccine within the past 30 days
- Receipt of immune globulin, blood transfusion or blood-derived product in the past 3 months
- Recent history of fever or underlying medical problems
Key Trial Info
Start Date :
June 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2001
Estimated Enrollment :
1913 Patients enrolled
Trial Details
Trial ID
NCT00984295
Start Date
June 1 2000
End Date
December 1 2001
Last Update
August 7 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.